Studies of bacteriophage as therapeutic agents have had mixed and unpredictable outcomes. We argue that interpretation of these apparently paradoxical results requires appreciation of various density-dependent threshold e!ects. We use a mathematical model to delineate di!erent categories of outcome, including therapy by simple inundation, by active biocontrol, and by delayed active biocontrol. Counter-intuitively, there are situations in which earlier inoculation can be less e$cacious, and simultaneous inoculation with antibiotics can be detrimental. Predictions of therapeutic responses are made using formulae dependent on biologically meaningful parameters; experimental measurement of the parameters will be a prerequisite of application of the model to particular study systems. Such modelling can point to which aspects of phage biology might most fruitfully be engineered so as to enhance the viability of bacteriophage therapy.
Introduction
Given the apparently inexorable advent of the post-antibiotic era (Berkowitz, 1995; Tenover & Hughes, 1996) it is surprising how few rigorous studies have focussed on the therapeutic alternative of bacteriophage biocontrol. Two recent reviews (Barrow & Soothill, 1997; Alisky et al., 1998) summarize results from experimental work both on animals and on people. Although these reviews point clearly to the potential of phage therapy as a weapon against antibiotic-resistant bacteria under certain circumstances, they also serve to highlight our ignorance of important areas of the phage}bacteria interaction. Table 1 lists some typical results from experimental studies, illustrating the range of outcomes. All the phage listed demonstrated active replication in culture, and yet showed widely varying activity when used in living hosts. Although sometimes active phage replication is successfully found in vivo, more often than not there is no active replication, with therapeutic bene"ts only being obtained by using very large or repeated doses, or not at all.
This uncertainty of transfer from behaviour in culture to behaviour in live hosts has dogged studies of phage as putative therapeutic agents ever since the idea was "rst advocated during the 'Herelle in 1917) , this enthusiasm gradually waned following failure of various poorly conceived studies during the 1920s and 1930s, and almost completely lapsed once the introduction of antibiotics apparently obviated the need for other approaches. Various arguments have been pro!ered for the failure of the early studies, including lack of awareness of phage-bacteria speci"city, presence of contamination, horizontal transfer of toxins by temperate phage, action of host anti-phage immune responses, and emergence of phageresistant bacterial mutants.
In this paper, we suggest that many of the apparently enigmatic facets of phage behaviour are a simple consequence of kinetic properties of phage replication. We draw on an understanding of the principles of population dynamics to support this viewpoint, and to create a framework for a theory of the optimal treatment strategies in bacteriophage therapy. We construct a simple but generic mathematical model to capture the critical replication and densitydependent qualities of bacteria}bacteriophage interactions, based on a minimal set of the essential biological processes at work. The model allows formulae to be derived which predict therapy outcome dependent on the life-history parameters, the inoculum size, and the inoculum timing.
A Kinetic Model of Phage Infection

MODEL FORMULATION
Let x(t) represent the concentration of uninfected bacteria, y(t) the lytic bacteria, and v(t) the free phage. The change in concentrations over time are described by the di!erential equations dx dt "ax!bvx!H(t)x,
dy dt "ay#bvx!ky!H(t)y,
dv dt "k¸y!bvx!mv!h(t)v
Here a is the replication coe$cient of the bacteria, b is the transmission coe$cient, k the lysis rate,¸the burst size, and m the decay rate of free phage. We assume the replication rate of infected bacteria to be the same as for uninfected bacteria, but it would be easy to adapt the equations for situations where this assumption does not hold, by using a suitable rede"nition of the parameter k. The initial input of bacteria is of size x at time zero; inoculation of an amount v of phage is given at time t .
Any host responses against the bacteria or against the phage can be incorporated via the variables H(t) and h(t), respectively (here, and 38 FIG. 1. Di!erent qualitative outcomes of phage treatment. Times of inoculation are marked by arrows. In (a) and (b) relatively large doses of phage are administered. In (a) this results in almost immediate clearance of the bacterial infection; in (b) some reduction of the bacterial concentration is achieved without clearing the infection, allowing the bacterial population to regrow. In (c) a small dose of phage is given which results in control of the bacterial infection at a later point in time; in (d) delayed administration of phage also results in control of bacterial infection, but does so earlier and for a lower peak bacterial density. All graphs were computed from numerical solutions of eqns (1}3). The solid lines represent the total bacterial concentration (x(t)#y(t)), the dashed lines the fraction of phage-infected bacteria [y(t)]. In all simulations the initial dose of bacteria was x "1000, y "0. Time is measured in hours. (a) Parameters: a"0. 5, b"10\, k"5,¸"100, m"5 ; phage inoculation t "2.5, v "10. (b) As for (a) except v "10. (c) Parameters: a"0.3, b"10\, k"1.2, ¸"100, m"1.8 ; phage inoculation t "2.5, v "100. (d) As for (c) except t "12.5. throughout, we reserve the word &&host'' to refer to the host of the bacteria). There are many types of bacterial infections, including gastrointestinal infections, suppurative wound infections, antibiotic-associated dysbacteriosis, sepsis, and infections secondary to other conditions. Consequently, there are likewise many forms of natural host responses. In addition, there could be homeostatic immune mechanisms wherein the host responses to the bacteria a!ect the phage and vice versa. Rather than seeking the details of speci"c responses such as the e!ects of #ushing (diarrhoea), or of the immune system, we use the variables H(t) and h(t) to capture the role of the host in a generic manner.
This model is appropriate for lytic phage but not for temperate phage, which do not lyse bacteria but instead enter a latent lysogenic state. Temperate phage are not used in phage therapy because they reproduce more slowly and often code for toxin production.
For simplicity, the model does not include the possibility of bacterial growth constrained by target cell limitation. In the context of phage therapy, target cell limitation could change the details of the outcome, but would not change the qualitative features that we report here.
Exact parameter values are not widely reported, but are likely to vary considerably from system to system. Approximate estimates are available from modelling studies (Levin & Bull, 1996; Schrag & Mittler, 1996) , and by inference from time-series data in experimental studies (Smith & Huggins, 1982; Merril et al., 1996) . For computer simulations of the model we examined a range of values giving, where possible, biologically plausible rates of turnover, decay, lysis and burst size. The computer simulations demonstrate that even this &&minimal'' model is capable of exhibiting a range of qualitatively di!erent outcomes, using only a handful of di!erent initial conditions and di!erent parameter values. Figure 1 (a) shows how a su$ciently large dose of phage can eradicate the bacteria even without active replication; Fig. 1(b) shows how a slightly smaller initial dose might result in only a transient inundation e!ect; Fig. 1(c) shows how for di!erent parameter values a small dose can be su$cient to lead to active replication of phage that subsequently fully subdues the bacterial infection; comparison of Fig. 1(c) with Fig. 1(d) illustrates an interesting e!ect*that this form of active therapy can sometimes be more e$cacious when the time of inoculation is delayed [ Fig. 1(d) uses identical parameters and initial conditions as Fig. 1(c) , except for timing of phage inoculation, as marked by arrows].
BACTERIOPHAGE THERAPY This diversity of results may seem bewildering, but in the next section we show how it is possible to analytically predict the circumstances under which these and other categories of outcome manifest.
CRITICAL CONCENTRATIONS AND CRITICAL TIMES
There is a threshold density of bacteria that must be present in order for the virus numbers to increase, which we shall refer to as the proliferation threshold, X .
(this is analogous to the eradication threshold used by epidemiologists). This threshold can be calculated from the condition that the basic reproductive number of the phage is greater than one (Anderson & May, 1992) . The basic reproductive number, R , is de"ned as the number of secondary infections per infected cell. Each infected bacterial cell can divide and will thus give rise to a cell line which, on average, will exist for a time 1/(k!a), during which this lineage will produce¸k/(k!a) virus particles. Each of these will cause on average bx/(bx#m) new infections. The total number of secondary infections per infection is therefore
.
Because the basic reproductive number of the phage depends on the density of bacteria, the appropriate condition for R '1 can be expressed in a convenient form: the phage and the lytic bacteria increase in number only when x(t)'X . , where
The concentration of bacteria may be reduced either by the host's own responses or by the action of the phage. The former occurs when the function describing the host response, H(t), exceeds the basic replication rate of the bacteria, a. The latter occurs when the concentration of free phage, v(t), exceeds a critical threshold, < ' , de"ned by
This viral inundation threshold, < ' , only expresses whether the phage can to some degree reduce the number of bacteria. Whether or not the phage will actually succeed in clearing the bacterial infection is a di!erent matter. Under inundation therapy (passive therapy) the bacteria will be cleared if the inoculum of phage is greater than a certain threshold, < ! say. During such clearance the role of secondary infection is negligible, and so we can approximate the behaviour of the phage by ignoring the lysis term, so that dv/dt+ !bvx!mv. The behaviour of the uninfected bacteria is dominated by the transmission term, so that dx/dt+ !bvx. We now consider the expression
This has an explicit solution obtainable from integration by separation of variables. We thereby obtain a relationship between x and v:
To calculate the clearance threshold < ! we apply the condition that clearance continues right up to the time when the uninfected bacteria disappear, that is v( )'< ' where is such that x( )" , and is the concentration equivalent to only one bacterial cell remaining. Substituting into the above equation and rearranging yields the condition for full clearance under passive therapy to be v '< ! where
If at any point in time both the inundation threshold < ' is exceeded by the virus concentration, and the proliferation threshold X . is exceeded by the bacterial concentration, then there will be active replication of the virus and explosive growth in viral numbers will ensue. In this way, the bacterial infection will rapidly be brought under control. This is the primary outcome to which biocontrol by bacteriophage therapy aspires. On the other hand, if < ' is exceeded, 40 but X . and < ! are not, then there will be an overall removal of bacteria by passive infection, but there will be no apparent active replication of the virus. The concentration of virus decreases until it becomes smaller than < ' , at which point if any bacteria remain they will begin to increase once more. In this case, because there is no active replication, the phage is acting in a manner little di!erent from antibiotic treatments, with only a temporary e!ect and none of the bene"ts of active phage replication.
If X . is not exceeded at the time of phage inoculation, it is still possible that, with the exponentially increasing bacterial numbers, the threshold will be surpassed at a later time. There is thus an intrinsically temporal context to the problem, imposed by the critical moment at which the bacterial density passes the proliferation threshold. We shall call this the proliferation-onset time, ¹ . . Whether or not active phage replication is achieved depends on two factors: whether there is still any phage present when the proliferation-onset time is reached; and/or whether the proliferation-onset time occurs prior to the time when any natural host responses manifest.
It is useful to consider the time-scale of onset of the host responses in the absence of phage. Let ¹ & be the time when the host might itself gain the upper hand over the bacteria [de"ned as H(¹ & )"a (in the absence of phage)]. This will of course depend on the nature of the host's defence systems and the context of the infection. But, unlike ¹ . , this time can be measured directly by experiment, and so the precise details of the dynamics need not concern us at present: merely the existence of the host response at time ¹ & , without details, is enough to allow us to proceed.
Because a prerequisite of achieving &&active therapy'' (i.e. removal of bacteria sustained by actively replicating phage) is that the phage density exceeds the proliferation threshold before the onset of the host response (i.e. ¹ .
, it is useful to have an estimate of the size of ¹ . . This is straightforward for the case when the initial inoculum of phage is less than the inundation threshold. Prior to inoculation the uninfected bacteria increase exponentially with x(t)"x e?R, and hence at the time of inoculation x "x e?R . This allows us to calculate the proliferation onset time using the condition x(¹ . )"X . , to give
The "nal threshold de"nition relates to the requirements to prevent the phage becoming fully purged from the system prior to ¹ . . A certain timing and size of phage inoculum is needed for there still to be some phage present at the time when X . is surpassed, and thus is required for active phage replication to become possible. This threshold can be thought of either in terms of a critical inoculation size (< $ ) for a given inoculation time, or a critical inoculation time (¹ $ ) for a given inoculation size. Prior to ¹ . the behaviour of the uninfected bacteria is dominated by the growth term, so that dx/dt+ax. At the same time the numbers of infected bacteria will always be very small, which means that a quasi-steadystate hypothesis can be imposed on eqn (2) (Murray, 1989) , so that we approximate y(t) "bv(t) x(t)/(k!a) (the time taken to reach this pseudo-equilibrium state introduces a small error to the estimates given below). Substituting for y(t) into dv/dt and using eqn (4) we can write the expression
Integration by separation of variables yields the relationship
To calculate the threshold < $ we apply the condition that some phage are still present when the proliferation onset time is reached, that is v(¹ . )' , where is the concentration equivalent to only one phage being present. Substituting into the above equation and writing x "x e?R gives the condition v '< $ , where
BACTERIOPHAGE THERAPY One cannot rewrite this explicitly for ¹ $ , although a "rst approximation is possible when t ¹ . . In this case, the condition is that t '¹ $ , where
For a given initial dose size, attempts at active therapy will fail outright if treatment is made prior to the failure threshold time ¹ $ .
CATEGORIES OF BEHAVIOUR AND
CATEGORIES OF OUTCOME By consideration of the above thresholds it is possible to delimit various categories of dynamic behaviour. The actual outcome of disease in any particular case then depends on the order of progression through those categories. From these categories of behaviour only certain sequences are possible, each with di!erent implications for the e!ectiveness of the phage therapy. The main categories of outcome, and the associated ordering of dynamical behaviours, are summarized in Table 2 .
The di!erence between active and passive removal of bacteria is apparent in the experimental results of Tolkachera et al. (1981 , cited in Alisky et al., 1998 , who compared the use of coli} Proteus phage and anti-pseudomonas phage as part of treatment of dysentery in immunosuppressed leukaemia patients. Patients given anti-pseudomonas phage recovered after only one course. Patients given coli}Proteus needed 2}3 courses to e!ect recovery, and Proteus concentrations declined only during each course, showing renewed multiplication between courses. This clearly indicates that the coli}Proteus was only able to be passively e!ective, with clearance of the bacteria being achieved only as a result of repeated administration of the phage. In contrast, the behaviour of anti-pseudomonas phage is consistent with actively e!ective therapy. In terms of our model these di!erent outcomes are interpreted as the types of phage having di!erent values of the proliferation threshold X . . The concentration of bacteria in the 42 
Passive-delay-active therapy patients was su$cient to support invasion and continued-secondary phage replication by antipseudomonas, but not by coli}Proteus.
Another study in which the action of the phage was only passive was reported by Berchieri et al. (1991) , who used Salmonella phage to treat chicks orally infected with Salmonella typhimurium. Although mortality was reduced from 60 to 3%, large numbers of phage were needed and there was no evidence of in vivo phage multiplication. This indicates that the concentration of S. typhimurium was less than the threshold X . , being insu$cient to support invasion by the Salmonella phage. In addition, the large number of phage required re#ects the need for the phage inoculation concentration to surpass the threshold < ' . Strong in vivo active replication, implying a low and easily surpassed value of X . , has been reported for anti-K1 phage used against E. coli infection in mice (Smith & Huggins, 1982) and cattle (Smith et al., 1987a) .
Our model predicts that actively e!ective therapy is dependent on the concentration of bacteria whereas passively e!ective therapy is dependent on the concentration of the phage. A consequence of this is that if active therapy is possible, then it may proceed even with low initial phage dosage, whereas passive therapy will not occur at all unless the initial phage dosage exceeds < ' . This is nicely illustrated in experiments by Soothill (1992) on the ability of three species of phage to control the three bacteria species Acinetobacter baumannii AC54, Pseudomonas aeruginosa 3719, and Staphylococcus aureus 6409 (all of which are implicated in infections of burns patients, and which frequently show antibiotic resistance). Treatment of A. baumannii with acinetobacter phage was very e!ective, being achieved with doses as low as one phage per 10 bacteria, there being a 10-fold in vivo increase in phage numbers. This is a clear case of actively e!ective therapy, although the data are not su$cient to distinguish between immediately active phage multiplication and delayed active multiplication. In the other two systems in vivo phage proliferation was not observed, despite being possible in vitro, suggesting these systems to have higher (unsurpassed) proliferation thresholds than in the acinetobacter system. Treatment of P. aeruginosa was only e!ective for doses of pseudomonas phage greater than 1.2;10 particles, supporting the notion that passively e!ective therapy requires a threshold phage concentration to be exceeded, in this case with < ' &1.2;10 particles. Attempts to treat S. aureus with staphylococcal phage failed at all dosages, implying a much higher value of < ' , and possibly also a late timing of ¹ $ . These results illustrate how quantitative measurements of dosages required for clearance of in vitro broth culture do not provide a simple prediction of the qualitative (5) and (6), respectively. Simulations were performed using various forms of host response (for example, the speci"c immune response form used by Levin & Bull, 1996) , but it was found that in this context the details were not important. Parameters as in Fig. 1(a) and (b), with phage administered at t"2.5. nature of in vivo outcome. To extrapolate from in vitro measurements to in vivo expectations requires appreciation that kinetic behaviour is realized in a context of density-dependent thresholds.
Therapeutic Implications
The relative magnitudes of the expected time of onset of host defences (¹ & ) and the projected time of initiation of active phage replication (¹ . ) will be critical in determining the therapeutic outcome. The actual time of recovery cannot be precisely predicted, but in most cases will follow rapidly after whichever occurs "rst out of
. In principle, these two time-scales could be comparable, leading to a degree of interaction, but for the present paper we restrict attention to when either one term or the other dominates. . This means that the phage never has su$cient time to bring the bacteria under control, and the only mode by which the phage may potentially contribute is via passive therapy (I). To actually do so requires a minimum dosage of v '< ' . Under these conditions the rule is simple: the larger and earlier the dose of phage the better. Figure 2 shows the role of < ' and < ! for an example in which the host response is assumed to become signi"cant at a time of ten time units following initial infection. The calculated estimates for < ' and < ! are marked. We have used the maximal bacterial concentration as a simple measure of disease severity. For Fig. 2 the maximal bacterial concentration coincides with the time when the host responses "rst become signi"cant (in contrast, for Fig. 3 , the maximal bacterial concentration occurs when the phage gains the upper hand over the bacterial infection*cf. Fig. 1(c) &&active'' (III) or the &&delayed active'' (IIa) categories. In this case, the optimal time of inoculation is actually at the boundary of these two categories, at the threshold time t "¹ . . To inoculate earlier is to place the system in the quiescent phase during which much of the phage will be lost while waiting for the active phase to start. To inoculate later is to waste useful time during which phage could actively multiply with positive feedback. Thus, if a species of phage has the potential for active therapeutic control, then it is not true to say that earlier inoculation is necessarily better: an intermediate time is optimal. Figure 3 gives example results of numerical solutions that illustrate both points just made. First, the severity of disease (y-axis) is minimized when the time of inoculation is close to the calculated value of ¹ . . Second, it is possible for treatment to occur so early that no therapeutic e!ect at all is achieved. The failure threshold time ¹ $ depends on the size of the initial dose; the smaller the inoculum of phage, the later the failure threshold, and the more likely it is that no phage will be left in the system by the time active replication becomes feasible. This accounts for the sudden vertical termination of the curve towards the left-hand side. For a given initial (7) and (9), respectively. Parameters as in Fig. 1 (c) and (d).
dosage it is possible to predict an approximate value of this lower failure threshold time using eqn (7).
Finally, consider what happens when there is the potential for both a period of initial passive therapy and a subsequent delayed period of active therapy (seventh entry in Table 2 ). An interesting point here is that, because there is initially passive removal of bacteria, the time when the proliferation threshold is passed becomes postponed. Although it is in principle possible to derive a modi"ed form of eqn (6) to account for this type of case, it is di$cult to predict the consequences for overall e$cacy of therapy, and thus this situation may be best considered on a case-by-case basis. Whether or not such dualphase outcomes are ever likely to occur in practice is unclear.
Although a number of studies have presented data describing the time course of infection (Smith & Huggins, 1982 , and the importance of timing relative to feeding for oral administration has been noted (Smith et al., 1987b) , there are as yet no explicit studies of the dependency of outcome upon inoculation time. The pivotal role of the proliferation onset time will only be relevant for phage that show in vivo activity, and is likely to be more readily observable for low initial bacterial doses.
ANTIBIOTICS
Few experimental studies have investigated the therapeutic potential of simultaneous treatment with phage and antibiotics. Slopek et al. (1983) found concomitant administration of antibiotics to diminish e$cacy of phage therapy from 95.2 to 84.9%. Sakandelidze (1991 , cited in Alisky et al., 1998 found a less emphatic reduction from 86.3 to 82.5%, in combination treatment of infections secondary to allergic rhinitis, dermatitis and conjunctivitis.
Our model can be adapted to predict the in#u-ence of such concomitant antibiotic inoculation, by adding an extra equation for antibiotic concentration (t) of the form
and appending terms ! xc and ! yc to eqns (1) and (2), respectively. The decay term n(t) may be time-dependent, according to the nature of any host responses. The consequences of using an antibiotic adjuvant depend on whether or not active viral replication occurs.
(i) Antibiotics with passive therapy. Antibiotics have a direct e!ect by reducing the growth rate of bacteria so that the magnitude of infection is lessened at the the point when host responses take over. There is also an indirect e!ect because the presence of antibiotics lowers the size of the inundation threshold, making passive removal of bacteria more likely. Both of these factors make the use of antibiotics bene"cial to the operation of passive therapy. the critical thresholds on the size of a: dX .
. Hence, adding antibiotics increases both the proliferation threshold and the proliferation onset time. But, because the optimal inoculation time is at t ( "¹ . , the e!ect of the addition of antibiotics depends on whether or not the consequent increase in ¹ . brings it closer to t ( . If t ( '¹ . then increasing ¹ . will be bene"-cial, in which case the presence of antibiotics will enhance the e!ect of phage therapy. But if t (
lengthens the duration of the quiescent phase, and thus reduces the period of active therapeutic value, this being detrimental to the e$cacy of phage therapy. Equation (7) points to another, possibly more important consequence of increasing ¹ . . When using an antibiotic adjuvant, the failure threshold time ¹ $ is pushed back in time (to ¹* $ , say), making outright failure of therapy more likely. Figure 4 illustrates both of these phenomena.
Discussion
Many ideas have been o!ered as to why studies of phage therapy are so prone to failure. We suggest that an important factor has been a lack of awareness of density-dependent phenomena that are intrinsic to self-replicating agents, but that do not occur with standard pharmaceuticals. Although failure of therapy is often attributed to low activity in vivo compared with in vitro, this is not of itself a reason: one must understand why there should be such a disparity between in vivo and in vitro.
In kinetic terms there are four basic issues important in determining the nature of the outcome of phage therapy. (i) Is the phage able to cause a net reduction in bacterial numbers simply by inundation (&&passive therapy'')? This requires the concentration of phage to exceed the inundation threshold (< ' ).
(ii) Is the phage able to bring about complete clearance by inundation alone? This requires the concentration of phage to exceed a higher threshold, the clearance threshold (< ! ). (iii) Is the phage able to persist long enough to commence active replication (&&active therapy'')? This depends both on the bacterial numbers exceeding a speci"c level which we call the proliferation threshold (X . ), and on the timing of phage inoculation being late enough [later than
(iv) Can active replication bring the bacterial infection to crisis before the onset of any natural host response? This requires the proliferation onset time to be less than the time-scale of natural host responses (¹ . (¹ & ). We have used the phrase &&passively e!ective'' to describe cases when most bacteria are removed by lysis following primary infection by the inoculated phage, whereas by &&actively e!ective'' we mean that secondary infection by lysis-released phage is the dominant cause of bacterial removal. The di!erence between actively and passively e!ective removal is a dichotomy that pervades all forms of biocontrol. For instance, application of baculoviruses as insecticides can either be inundative, with the objective of a rapid kill time, or low level, with the aim of taking advantage of the natural virus replication. The secondary infection resulting from virus replication can lead to a higher insect mortality overall, but acts only over a longer time-scale (Fuxa, 1987; Hauxwell, 1999 Although passive biocontrol can be e!ective, it will usually require large and repeated dosages for success to be ensured. In contrast, any biocontrol agent with in vivo activity need only be given as one dose, and typically that dose need only be small. We argue that to maximize this bene"t, the phage inoculation should be administered as close as possible to the proliferation threshold, ¹ . . This prediction from our model could easily be tested experimentally. It is worth noting that the time of ¹ . will be later, and hence easier to detect, for smaller initial doses of bacteria. Most laboratory studies, based on LD and/or PD measures, use large bacterial doses that may obscure this e!ect, and that do not accurately mimic the probably small inoculum size in natural systems. All of the parameters de"ning ¹ .
[eqn (7)] are in principle independently measurable, and so it may even be feasible to predict values of ¹ . for speci"c study systems. Because the parameters are biologically meaningful, most of them should be measurable in vitro. It should also be practicable to test our predictions concerning ¹ $ [eqn (9)], and < ' [eqn (5)], and concerning the consequences of simultaneous administration of antibiotics.
In this report, we have used the simplifying assumption that if any host response occurs, it will be relatively rapid and complete. Not all real situations will be of such a simple form, having perhaps only slow or partial clearance of the bacteria by the host. In such cases, the functions H(t) and h(t) which describe the host responses would have to be modelled accordingly, perhaps with their own dynamic equations (such as the dynamic immune response in Levin & Bull, 1996) . Although such cases will need more complex mathematics, the thresholds and other phenomena we have described will nonetheless remain relevant, albeit with formulae modi"ed to account for the details of each particular scenario. Modelling the immune dynamics of speci"c systems will be an important objective of future studies.
Most models of phage}bacteria interactions have been aimed at addressing co-evolutionary questions. To date, the only serious attempt to model the dynamics of phage therapy as a population biology phenomenon was that by Levin & Bull (1996) , whose model was designed to re#ect data from the Smith & Huggins (1982) study of phage used against E. coli infection in mice. The mathematical formulation presented by Levin and Bull did not include a term for loss of phage, and for this reason neither the proliferation threshold, X . nor any of the consequent phenomena, would have been apparent. The fact that a signi"cant proportion of laboratory studies exhibit only passively e!ective therapy clearly indicates loss of phage to be an important factor in phage}bacteria population dynamics, and underlines the necessity of including a phage loss term in our model. Merril et al. (1996) described a study speci"cally aimed at reducing the magnitude of phage loss, by selecting for long-circulating strains of E. coli phage and of S. typhimurium phage P22, able to avoid entrapment by the reticuloendothelium system. In our model, this is equivalent to decreasing the size of m, the parameter for rate of phage loss. This consequently reduces the size of the proliferation onset time, the failure threshold time, and the clearance threshold. Our formulae make explicit the mechanisms by which these e!ects occur. Long-circulating strains will also aid potential use of phage in a prophylactic rather than merely curative capacity (cf. Smith et al., 1987a, b) .
Our model is able to mimic a range of observed behaviours without recourse to inclusion of the details of the pathophysiology. This argues not only for the robustness and generality of our model, but also illustrates that many of the apparently paradoxical aspects of phage therapy are not of genetic or molecular origin, but arise from nonlinear density-dependent phenomena. A natural consequence of the density-dependent nature of the phage}bacteria interaction is that the timing of events is important. For most diseases it is important to administer treatment as early as possible, yet we have shown this not to be the case for phage therapy. If one wishes to bene"t from active phage replication then early treatment can be detrimental. Moreover, using parallel administration of phage and antibiotics BACTERIOPHAGE THERAPY is a practice one should be wary of*as we have shown, the antibiotics can often act against the interests of the phage. Both of these counterintuitive, yet clinically important issues, only make sense when viewed as density-dependent phenomena constrained by critical time points. Even if variation amongst individual patients cannot be resolved at a clinical level, a quantitative understanding of phage}bacteria kinetics is still of signi"cant bene"t (Payne & Jansen, 2000) , for it informs us which aspects of phage biology might best be engineered so as to enhance the prospects of phage therapy.
The reviews of Barrow & Soothill (1997) and Alisky et al. (1998) both conclude that bacteriophage show increasing promise as antimicrobial agents, warranting greater investment in their investigation and development. The replication of phage, their narrow host range, and their potential for directed evolution, gives phage therapy a number of unique advantages over antibiotics. To pro"t from the putative bene"ts of phage therapy will not only require intimate knowledge of the pathogenesis of infection, as discussed by Barrow & Soothill (1997) , but will also depend upon interpreting that knowledge within the density-dependent framework that we have set forth above.
